Contact Info & Biography
Education & Training
Memberships & Awards

Monique Verhaegen, PhD

Research Assistant Professor

Selected Publications

  1. Bortolin S, Christopoulos TK, Verhaegen M. Quantitative polymerase chain reaction using a recombinant DNA internal standard and time-resolved fluorometry. Anal Chem. 1996;68:834-840.
  2. Verhaegen M, Iannou P, Christopoulos TK. Quantification of prostate specific antigen and mRNA by co-amplification with a recombinant RNA internal standard and microtiter well-based hybridization. Clin Chem. 1998;44:1170-1176.
  3. Verhaegen M, Christopoulos TK. Quantitative polymerase chain reaction based on a dual-analyte chemiluminescent hybridization assay for target DNA and internal standard. Anal Chem. 1998;70:4120-4125.
  4. Verhaegen M, Christopoulos TK. Bacterial expression of In vivo biotinylated aequorin and application to bioluminometric hybridization assays. Anal Biochem. 2002;306:314-322.
  5. Verhaegen M, Christopoulos TK. Recombinant Gaussia Luciferase. Overexpression, purification, and analytical application of a new reporter for DNA hybridization. Anal Chem. 2002;74:4378-4385.
  6. Tannous B, Verhaegen M, Christopoulos TK. Combined flash- and glow-type chemiluminescent reactions for high-throughput genotyping of biallelic polymorphisms. Anal Biochem. 2003;320:266-272.
  7. Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW, Lowe SW, Soengas MS. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res. 2005;65(14):6294-6304.
  8. Pilon-Thomas S, Verhaegen M, Kuhn L, Riker A, Mule JJ. Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells. Cancer Immunol Immunother. 2006;55(10):1238-1246.
  9. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian BC, Soengas MS. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol. 2006;8(10):1053-1063.
  10. Konopleva M, Contractor R, Tsao T, Ruvolo PP, Samudio I, Kitada S, Deng X, Zhai D, Yuexi S, Sneed T, Verhaegen M, Soengas M, Ruvolo VR, McQueen T, Schober WD, Watt JC, Jiffar, T., Ling X, Marini F, Harris D, Dietrich M., Estrov Z, McCubrey J, May WS, Reed JC, and Andreeff M. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006;10(5):375-388.
  11. Verhaegen M, Bauer JA, Martin de la Vega C, Wang G, Wolter KG, Brenner JC, Nikolovska-Coleska Z, Bengtson A, Nair R, Elder JT, Carey TE, Bradford CR, Wang S, Soengas MS. A novel BH3 mimetic reveals a MAPK-dependent mechanism of melanoma cell survival controlled by p53 and reactive oxygen species. Cancer Res. 2006;66(23):11348-11359.
  12. *Wolter KG, *Verhaegen M, Fernandez Y, Nikolovska-Coleska A, Bengtson A, Wang S. and Soengas MS. Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins. Cell Death Differ. 2007;14(9):1605-1616. *authors contributed equally


U-M Medical School | U-M Gateway
© Copyright 2014-2017 Regents of the University of Michigan | Disclaimer |
Privacy Statement
Developed and maintained by Michigan Multimedia, Medical School Information Services
Contact Michigan Medicine


Michigan Medicine Home
Health Topics A-Z
For Patients & Families
For Health Providers